Twist Bioscience
TWST
103.32
-8.30
-7.44%
Twist Bioscience
US · TWST
#1258 by market cap
Listed 2018
103.32
-8.30
-7.44%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:52
About Twist Bioscience
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.
- Founded
- 2013
- CEO
- Dr. Emily M. Leproust, PhD
- Employees
- 979
- Headquarters
- San Francisco, California, United States of America
- Fiscal year end
- 09-30
- Website
- twistbioscience.com
Company profile
- Exchange
- US
- Symbol
- TWST
- Market-cap rank
- #1258
- Listing date
- 2018-10-31
- Market cap
- 6.85B
- Float cap
- 6.77B
- Shares out
- 66.30M
- Float shares
- 65.48M
Sectors & themes
Quote time 2026-11-20 19:52:04 · For reference only, not investment advice and not tailored to your situation.
Twist Bioscience discussion 0 comments